vs
Side-by-side financial comparison of GREENE COUNTY BANCORP INC (GCBC) and Sanara MedTech Inc. (SMTI). Click either name above to swap in a different company.
Sanara MedTech Inc. is the larger business by last-quarter revenue ($27.5M vs $22.2M, roughly 1.2× GREENE COUNTY BANCORP INC). GREENE COUNTY BANCORP INC runs the higher net margin — 46.3% vs -5.9%, a 52.2% gap on every dollar of revenue. On growth, GREENE COUNTY BANCORP INC posted the faster year-over-year revenue change (23.8% vs 4.6%). GREENE COUNTY BANCORP INC produced more free cash flow last quarter ($6.2M vs $3.9M). Over the past eight quarters, Sanara MedTech Inc.'s revenue compounded faster (21.8% CAGR vs 18.9%).
Bank of Greene County is an American federally-chartered savings bank headquartered in Catskill, NY. The bank's branches are located in the Upstate New York counties of Greene, Columbia, Albany, Ulster, and Rensselaer.
Sanara MedTech Inc. is a US-based medical technology company that develops, manufactures, and distributes innovative surgical, wound care, and post-acute rehabilitation products. It mainly serves healthcare providers, hospitals, and long-term care facilities across North America, with a portfolio of FDA-cleared solutions designed to improve patient outcomes and lower clinical care operational costs.
GCBC vs SMTI — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $22.2M | $27.5M |
| Net Profit | $10.3M | $-1.6M |
| Gross Margin | — | 93.2% |
| Operating Margin | 52.0% | 23.5% |
| Net Margin | 46.3% | -5.9% |
| Revenue YoY | 23.8% | 4.6% |
| Net Profit YoY | 37.4% | 5.3% |
| EPS (diluted) | $0.60 | $-0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $22.2M | $27.5M | ||
| Q3 25 | $21.5M | $26.3M | ||
| Q2 25 | $20.5M | $25.8M | ||
| Q1 25 | $20.1M | $23.4M | ||
| Q4 24 | $17.9M | $26.3M | ||
| Q3 24 | $16.9M | $21.7M | ||
| Q2 24 | $16.6M | $20.2M | ||
| Q1 24 | $15.7M | $18.5M |
| Q4 25 | $10.3M | $-1.6M | ||
| Q3 25 | $8.9M | $-30.4M | ||
| Q2 25 | $9.3M | $-2.0M | ||
| Q1 25 | $8.1M | $-3.5M | ||
| Q4 24 | $7.5M | $-1.7M | ||
| Q3 24 | $6.3M | $-2.9M | ||
| Q2 24 | $6.7M | $-3.5M | ||
| Q1 24 | $5.9M | $-1.8M |
| Q4 25 | — | 93.2% | ||
| Q3 25 | — | 92.9% | ||
| Q2 25 | — | 92.5% | ||
| Q1 25 | — | 92.2% | ||
| Q4 24 | — | 91.4% | ||
| Q3 24 | — | 90.8% | ||
| Q2 24 | — | 90.0% | ||
| Q1 24 | — | 89.8% |
| Q4 25 | 52.0% | 23.5% | ||
| Q3 25 | 47.4% | 11.2% | ||
| Q2 25 | 53.5% | -0.1% | ||
| Q1 25 | 44.6% | -8.9% | ||
| Q4 24 | 45.0% | 18.6% | ||
| Q3 24 | 39.6% | 3.6% | ||
| Q2 24 | 41.2% | -14.3% | ||
| Q1 24 | 39.4% | -8.3% |
| Q4 25 | 46.3% | -5.9% | ||
| Q3 25 | 41.2% | -115.5% | ||
| Q2 25 | 45.6% | -7.8% | ||
| Q1 25 | 40.1% | -15.1% | ||
| Q4 24 | 41.7% | -6.5% | ||
| Q3 24 | 37.1% | -13.2% | ||
| Q2 24 | 40.6% | -17.4% | ||
| Q1 24 | 37.3% | -9.5% |
| Q4 25 | $0.60 | $-0.32 | ||
| Q3 25 | $0.52 | $-3.40 | ||
| Q2 25 | $0.55 | $-0.23 | ||
| Q1 25 | $0.47 | $-0.41 | ||
| Q4 24 | $0.44 | $-0.18 | ||
| Q3 24 | $0.37 | $-0.34 | ||
| Q2 24 | $0.39 | $-0.41 | ||
| Q1 24 | $0.34 | $-0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $16.6M |
| Total DebtLower is stronger | — | $46.0M |
| Stockholders' EquityBook value | $258.3M | $5.9M |
| Total Assets | $3.1B | $72.9M |
| Debt / EquityLower = less leverage | — | 7.74× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $16.6M | ||
| Q3 25 | — | $14.9M | ||
| Q2 25 | — | $17.0M | ||
| Q1 25 | $155.5M | $20.7M | ||
| Q4 24 | $166.4M | $15.9M | ||
| Q3 24 | — | $16.3M | ||
| Q2 24 | $190.4M | $6.2M | ||
| Q1 24 | — | $2.8M |
| Q4 25 | — | $46.0M | ||
| Q3 25 | — | $45.1M | ||
| Q2 25 | — | $44.2M | ||
| Q1 25 | — | $43.4M | ||
| Q4 24 | — | $30.7M | ||
| Q3 24 | — | $30.1M | ||
| Q2 24 | — | $14.4M | ||
| Q1 24 | — | $9.7M |
| Q4 25 | $258.3M | $5.9M | ||
| Q3 25 | $248.2M | $6.1M | ||
| Q2 25 | $238.8M | $35.4M | ||
| Q1 25 | $229.0M | $36.7M | ||
| Q4 24 | $218.4M | $39.4M | ||
| Q3 24 | $216.3M | $39.8M | ||
| Q2 24 | $206.0M | $41.7M | ||
| Q1 24 | $199.2M | $43.3M |
| Q4 25 | $3.1B | $72.9M | ||
| Q3 25 | $3.1B | $71.1M | ||
| Q2 25 | $3.0B | $98.8M | ||
| Q1 25 | $3.0B | $96.4M | ||
| Q4 24 | $3.0B | $88.1M | ||
| Q3 24 | $2.9B | $88.5M | ||
| Q2 24 | $2.8B | $73.4M | ||
| Q1 24 | $2.9B | $70.9M |
| Q4 25 | — | 7.74× | ||
| Q3 25 | — | 7.33× | ||
| Q2 25 | — | 1.25× | ||
| Q1 25 | — | 1.18× | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | 0.76× | ||
| Q2 24 | — | 0.34× | ||
| Q1 24 | — | 0.22× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $6.4M | $3.9M |
| Free Cash FlowOCF − Capex | $6.2M | $3.9M |
| FCF MarginFCF / Revenue | 28.0% | 14.0% |
| Capex IntensityCapex / Revenue | 0.9% | 0.3% |
| Cash ConversionOCF / Net Profit | 0.62× | — |
| TTM Free Cash FlowTrailing 4 quarters | $47.3M | $2.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $6.4M | $3.9M | ||
| Q3 25 | $7.0M | $2.2M | ||
| Q2 25 | $28.0M | $2.7M | ||
| Q1 25 | $7.3M | $-2.0M | ||
| Q4 24 | $5.3M | $932.0K | ||
| Q3 24 | $2.1M | $2.1M | ||
| Q2 24 | $24.9M | $-1.4M | ||
| Q1 24 | $5.6M | $-1.6M |
| Q4 25 | $6.2M | $3.9M | ||
| Q3 25 | $6.5M | $1.1M | ||
| Q2 25 | $27.3M | $902.7K | ||
| Q1 25 | $7.3M | $-3.7M | ||
| Q4 24 | $5.1M | $859.9K | ||
| Q3 24 | $2.0M | $2.0M | ||
| Q2 24 | $23.4M | $-1.5M | ||
| Q1 24 | $4.9M | $-1.7M |
| Q4 25 | 28.0% | 14.0% | ||
| Q3 25 | 30.4% | 4.2% | ||
| Q2 25 | 133.3% | 3.5% | ||
| Q1 25 | 36.1% | -15.9% | ||
| Q4 24 | 28.6% | 3.3% | ||
| Q3 24 | 11.8% | 9.4% | ||
| Q2 24 | 141.2% | -7.3% | ||
| Q1 24 | 31.3% | -9.0% |
| Q4 25 | 0.9% | 0.3% | ||
| Q3 25 | 1.9% | 4.0% | ||
| Q2 25 | 3.4% | 6.8% | ||
| Q1 25 | 0.3% | 7.4% | ||
| Q4 24 | 1.0% | 0.3% | ||
| Q3 24 | 0.9% | 0.0% | ||
| Q2 24 | 9.1% | 0.3% | ||
| Q1 24 | 4.2% | 0.4% |
| Q4 25 | 0.62× | — | ||
| Q3 25 | 0.78× | — | ||
| Q2 25 | 3.00× | — | ||
| Q1 25 | 0.91× | — | ||
| Q4 24 | 0.71× | — | ||
| Q3 24 | 0.34× | — | ||
| Q2 24 | 3.70× | — | ||
| Q1 24 | 0.95× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GCBC
Segment breakdown not available.
SMTI
| Soft Tissue Repair Products | $24.7M | 90% |
| Bone Fusion Products | $2.8M | 10% |
